| Odds ratio | 95% CI | p value |
---|---|---|---|
Clinical characteristics | Â | ||
HPV status | |||
Positive | Â | Â | Â |
Negative Untested | 1.00 (ref) 1.24 1.62 | – 0.11–14.31 0.12–21.13 | – 0.87 0.71 |
Lesion severity (post results) | |||
Low-grade High-grade | 1.00 (ref) 0.10 | – 0.00–0.30 | –  < 0.01 |
Type of follow-up | |||
Follow-up Treatment | 1.00 (ref) 3.91 | – 0.30–50.73 | – 0.30 |
Psychosocial characteristics | |||
State anxiety scale (baseline) (clinical cut-off) | |||
 < 40  ≥ 40 | 1.00 (ref) 1.21 | – 0.30–4.87 | – 0.79 |
Demographic characteristics | |||
Age (years) | 0.73 | 0.61–0.88 |  < 0.01 |
Born in Canada | |||
No Yes | 1.00 (ref) 5.35 | – 0.52–55.3 | – 0.16 |
Smoking status | |||
No Yes | 1.00 (ref) 22.46 | – 2.16–233.01 | –  < 0.01 |